Over the years, gut hormone mimetics, exemplified by GLP-1 receptor agonists and coagonists used to treat type 2 diabetes mellitus (T2DM) and obesity (4), have gained increasing attention. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.